500660:BOM
GlaxoSmithKline Pharmaceuticals Ltd
₹2,535.00
arrow_upward
+0.01%(+0.35) 1D
Oct 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 500660...
Open
₹2,510.25
High
₹2,563.90
Low
₹2,489.00
Mkt. cap
430.34B
Avg. vol.
7.44K
Volume
3.50K
Dividend
2.25%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.20
52-wk high
₹3,121.10
52-wk low
₹2,088.00
EPS
₹63.05
Shares outstanding
169.41M
No. of employees
3K
Open
₹2,510.25
High
₹2,563.90
Low
₹2,489.00
Mkt. cap
430.34B
Avg. vol.
7.44K
Volume
3.50K
Dividend
2.25%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.20
52-wk high
₹3,121.10
52-wk low
₹2,088.00
EPS
₹63.05
Shares outstanding
169.41M
No. of employees
3K
News stories
From web sources and news partners
JournalArta
·
3 hours ago
Stock Market Week Ahead: What to Know
ChartMill
·
1 day ago
Friday's session: top gainers and losers in the dow jones index
The Motley Fool
·
17 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
The Washington Post
·
1 day ago
How major US stock indexes fared Friday 10/9/2026
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1K
FoundedNov 13, 1924
Headquarters-
SectorPharmaceutical industry
Websiteindia-pharma.gsk.com